Annual Long Term Liabilities:
$226.34M+$129.25M(+133.12%)Summary
- As of today, RXRX annual total long term liabilities is $226.34 million, with the most recent change of +$129.25 million (+133.12%) on December 31, 2024.
- During the last 3 years, RXRX annual long term liabilities has risen by +$205.59 million (+990.87%).
- RXRX annual long term liabilities is now -53.02% below its all-time high of $481.77 million, reached on December 31, 2020.
Performance
RXRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Long Term Liabilities:
$151.59M-$5.24M(-3.34%)Summary
- As of today, RXRX quarterly total long term liabilities is $151.59 million, with the most recent change of -$5.24 million (-3.34%) on June 30, 2025.
- Over the past year, RXRX quarterly long term liabilities has increased by +$46.26 million (+43.92%).
- RXRX quarterly long term liabilities is now -68.53% below its all-time high of $481.77 million, reached on December 1, 2020.
Performance
RXRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RXRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +133.1% | +43.9% |
| 3Y3 Years | +990.9% | +9.6% |
| 5Y5 Years | +3.4% | - |
RXRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +990.9% | -3.3% | +703.0% |
| 5Y | 5-Year | -53.0% | +990.9% | -68.5% | +811.5% |
| All-Time | All-Time | -53.0% | +990.9% | -68.5% | +811.5% |
RXRX Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $151.59M(-3.3%) |
| Mar 2025 | - | $156.84M(+12.0%) |
| Dec 2024 | $226.34M(+133.1%) | $140.07M(+641.9%) |
| Sep 2024 | - | $18.88M(-82.1%) |
| Jun 2024 | - | $105.33M(+177.8%) |
| Mar 2024 | - | $37.92M(-27.9%) |
| Dec 2023 | $97.09M(-15.7%) | $52.58M(-1.4%) |
| Sep 2023 | - | $53.31M(+45.0%) |
| Jun 2023 | - | $36.77M(-65.0%) |
| Mar 2023 | - | $105.04M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $115.22M(+455.3%) | $115.22M(-18.0%) |
| Sep 2022 | - | $140.46M(+1.6%) |
| Jun 2022 | - | $138.28M(-10.8%) |
| Mar 2022 | - | $155.05M(+647.3%) |
| Dec 2021 | $20.75M(-95.7%) | $20.75M(+24.8%) |
| Sep 2021 | - | $16.63M(-36.9%) |
| Jun 2021 | - | $26.34M(-94.5%) |
| Mar 2021 | - | $478.12M(-0.8%) |
| Dec 2020 | $481.77M(+120.0%) | - |
| Dec 2020 | - | $481.77M |
| Dec 2019 | $219.01M | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual total long term liabilities?
- What is the all-time high annual long term liabilities for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly total long term liabilities?
- What is the all-time high quarterly long term liabilities for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual total long term liabilities?
The current annual long term liabilities of RXRX is $226.34M
What is the all-time high annual long term liabilities for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual total long term liabilities is $481.77M
What is Recursion Pharmaceuticals, Inc. annual long term liabilities year-on-year change?
Over the past year, RXRX annual total long term liabilities has changed by +$129.25M (+133.12%)
What is Recursion Pharmaceuticals, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of RXRX is $151.59M
What is the all-time high quarterly long term liabilities for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly total long term liabilities is $481.77M
What is Recursion Pharmaceuticals, Inc. quarterly long term liabilities year-on-year change?
Over the past year, RXRX quarterly total long term liabilities has changed by +$46.26M (+43.92%)